Journal articlePreclinical

Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents

The Journal of pharmacology and experimental therapeutics, 2013 Jan. McCoy AT, Benoist CC, Wright JW and 6 others.

Study type

Journal article

Subjects

Animal / preclinical (no Humans MeSH term)

Journal

The Journal of pharmacology and experimental therapeutics

Published

2013 Jan

PubMed

PMID 23055539 ↗

DOI

10.1124/jpet.112.199497 ↗

Full text

Free on PubMed Central (PMC3533412) ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Dihexa →

Indexed under

MeSH terms assigned by the National Library of Medicine.

Angiotensin IIAnimalsBlood-Brain BarrierChromatography, High Pressure LiquidDementiaDendritic SpinesHalf-LifeHippocampusHydrogen BondingImmunohistochemistryIn Vitro TechniquesMale

Other papers on Dihexa

Review · 2015

The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases

Journal article · 2025

Retraction notice to "The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System" [J Pharmacol Exp Ther 351 (2014) 390-402]

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page